Procalcitonin is a 14-kDa protein encoded by the Calc-I gene along with calcitonin and katacalcin. The function and regulation of this protein are quite different from those of the other gene products. Blood concentrations of procalcitonin are increased in systemic inflammation, especially when this is caused by bacterial infection. Studies of its behaviour in patients with bacterial sepsis have led to the proposal that it may be a useful marker of systemic bacterial infection, with greater specificity and sensitivity than acute phase proteins such as C-reactive protein.
References
1.
American College of Chest Physicians - Society of Critical Care Medicine Consensus Conference. Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med1992;20: 864–75.
2.
LaurellC-B.Acute phase proteins - a group of protective proteins. In: PriceCPAlbertiKGMM, eds. Recent Advances in Clinical Biochemistry, 3. New York: Churchill Livingstone, 1985: 103–24.
3.
Le MoullecJMJullienneAChenaisJLasmolesFGulianaJMMilhaudGThe complete sequence of human preprocalcitonin. FEBS Lett1984;167: 93–7.
4.
BroadPMSymesAJThakkerRVCraigRK. Structure and methylation of the human calcitonin/alpha-CGRP gene. Nucleic Acids Res1989;17: 6999–7011.
5.
AdemaGJBaasPD. A novel calcitonin-encoding mRNA is produced by alternative processing of calcitonin/calcitonin gene-related peptide-I-pre-mRNA. J Biol Chem1992;267: 7943–8.
6.
AmaraSGJonasVRosenfeldMGOngESEvansRM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature1982;298: 240–4.
7.
FisherLAKikkawaDORivierJEAmaraSGEvansRMRosenfeldMGStimulation of noradrenergic outflow by calcitonin gene-related peptide. Nature1983;305: 534–6.
8.
KawamuraNTamuraHObanaSWennerMIshikawaTNakataADifferential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation1998;5: 9–15.
9.
RosenfeldMGMermodJJAmaraSGSwansonLWSawchenkoPERivierJProduction of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature1983;304: 129–35.
10.
DandonaPNixDWilsonMFAljadaALoveJAssicotMProcalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab1994;79: 1605–8.
11.
AssicotMGendrelDCarsinHRaymondJGuilbaudJBohounC.High serum procalcitonin concentrations in patients with sepsis and infection. Lancet1993;341: 515–8.
12.
ColonJMGrimeliusLThimL.Structural characterisation of a high-molecuiar-mass form of calcitonin {procalcitonin-(60-116)-peptide} and its corresponding N-terminal flanking peptide {procalcitonin-(1-57)-peptide} in a human medullary thyroid carcinoma. Biochemistry1988;256: 245–50.
13.
GkonosPJBornWJonesBNPetermannJBKeutmannHTBirnbaumRSBiosynthesis of calcitonin gene-related peptide and calcitonin by a human medullary carcinoma cell line. J Biol Chem1986;261: 14386–91.
14.
BirnbaumRSMahoneyWCBurnsDMO'NeilJAMillerRERoosBA. Identification of procalcitonin in a rat medullary thyroid carcinoma cell line. J Biol Chem1984;259: 2870–4.
15.
CateCCPettengillOSSorensonGD. Biosynthesis of procalcitonin in small cell carcinoma of the lung. Cancer Res1986;46: 812–8.
16.
BeckerKLSniderRHSilvaOLMooreMF. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer. Acta Endocrinol1978;89: 89–99.
17.
BeckerKLMonaghanKGSilvaOL. Immunocytochemical localisation of calcitonin in Kulschitzky cells of human lung. Arch Pathol Lab Med1980;104: 196–8.
18.
OberhofferMStonansIRusswurmSStoaneEVogelsangHJunkerUProcalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysac-charides and sepsis related cytokines in vitro. J Lab Clin Med1999;134: 49–55.
19.
RusswurmSWiederholdWOberhofferMStonansIPeikerGReinhartK.Procalcitonin as monocytic marker for early diagnosis in septic abortus [in German]. Z Geburtsh Neonatol1999;203: 11–4.
20.
OberhofferMVogelsangHJägerEReinhartK.Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content. J Crit Care1999;14: 29–33.
21.
MonneretGLarocheBBienvenuJ.Procalcitonin is not produced by circulating blood cells. Infection1999;27: 34–5.
22.
NijstenMWNOlingaPTheHde VriesEGEKoopsHSGroothuisGMMProcalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med2000;28: 458–61.
23.
KettlehackCHohenbergerPSchulzeGKilpertBSchlagPM. Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumour necrosis factor-α and melphalan. Crit Care Med2000;28: 1040–6.
24.
SchmidtJMeisnerMTschaikowskyKSchüttlerJ.Procalcitonin modulates the proinflammatory response in vitro [in German]. Anästhesiol Intensivmed Notfallmed Schmerzther1997;32: S171.
25.
NylenESWhangKTSniderRHSteinwaldPMWhiteJCBeckerKL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med1998;26: 1001–6.
26.
RusswurmSWiederholdMOberhofferMStonansIZipfelPFReinhartK.Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med1999;37: 789–97.
27.
GhillaniPPMottePTroalenFJulienneAGardetPLe ChevalierTIdentification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res1989;49: 6845–51.
28.
MeisnerM.PCT - procalcitonin. A new and innovative parameter in diagnosis of infections. Berlin: Brahms Diagnostica, 1996: 14–60.
29.
MeisnerMTschaikowskyKSchnabelSSchmidtJKatalinicASchüttlerJ.Procalcitonin - Influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur J Clin Chem Clin Biochem1997;35: 597–601.
30.
MonneretGDocheCGiraudNBienvenuFBienvenuJ.Procalcitonin: analytical aspects and preliminary clinical data [in French]. Immunoanalt Biol Spéc1997;12: 118–21.
31.
MalletELanseXDevauxAMEnselPBasuyaiiJPBrunelleP.Hypercalcitoninaemia in fulminant meningococcaemia in children. Lancet, ii, 294.
32.
MimozOBenoistJFEdouardARAssicotMBohounCSamiiK.Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med1998;24: 185–8.
33.
ReithHBMittelkötterUDebusESKüssnerCThiedeA.Procalcitonin in early detection of postoperative complications. Dig Surg1998;15: 260–5.
34.
MeisnerMTschaikowskyKHutzlerASchickCSchüttlerJ.Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med1998;24: 680–4.
35.
BoekenUFeindtPPetzoldTKleinMMicekMSeyfertUTDiagnostic value of procalcitonin: the influence of cardiopulmonary bypass, aprotinin, SIRS and sepsis. Thorac Cardiovasc Surg1998;46: 348–51.
36.
HenselMVolkTDöckeWDKernFTschirnaDEgererKHyperprocalcitoninemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary by pass. Anesthesiology1998;89: 93–104.
37.
RothenburgerMMarkewitzALenzTKaulbachH-GMarohlKKuhlmannW-DDetection of acute phase response and infection. The role of procalcitonin and C-reactive protein. Clin Chem Lab Med1999;37: 275–9.
38.
NylenESO'NeillWJordanMHSniderRHMooreCFLewisMSerum procalcitonin as an index of inhalation burn injury in burns. Horm Metab Res1992;24: 439–43.
39.
NylenESJengJJordanMHSniderRHThompsonKALewisMSLate pulmonary sequela following burns: presence of hyperprocalcitoninemia using a 1–57 amino acid N-terminal flanking peptide assay. Respir Med1995;89: 41–6.
40.
NylenESSniderRHJrThompsonKARohatgiP.Becker KL. Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci1996;312: 12–8.
41.
de WerraIJaccardCCorradinSBChioléroRYersinBGallatiHCytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med1997;25: 607–13.
42.
OberhofferMVogelsangHRusswurmSHartungTReinhartK.Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med1999;37: 363–8.
43.
SchröderJStaubachK-HZabelPStüberFKremerB.Procalcitonin as a marker of severity in septic shock. Langenbeck's Arch Surg1999;384: 33–8.
44.
Al-NawasBKrammerIShahPM. Procalcitonin in diagnosis of severe infections. Eur J Med Res1996;1: 331–3.
45.
UgarteHSilvaEMercanDDe MendoncaAVincentJ-L.Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med1999;27: 498–504.
46.
MüllerBBeckerKLSchweningerHRickenbacherPRHuberPRZimmerliWCalcitonin precursors are reliable markers of sepsis in the medical intensive care unit. Crit Care Med2000;28: 977–83.
47.
WannerGAKeelMSteckholzerUBeierWStockerRErtelW.Relationship between procalcitonin plasma levels and severity of injury, organ failure, and mortality in injured patients. Crit Care Med2000;28: 950–7.
48.
MonneretGDocheCVital-DurandDLepapeABienvenuJ.Procalcitonin as a specific marker of bacterial infection in adults. Clin Chem Lab Med1998;36: 67–8.
49.
GendrelDAssicotMRaymondJMoulinFFrancoualCBadoualJProcalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr1996;128: 570–3.
50.
MonneretGLabauneJMIsaacCBienvenuFPutetGBienvenuJ.Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr1997;86: 209–12.
51.
SachseCDresslerFHenkelE.Increased serum procalcitonin in newborn infants without infection. Clin Chem1998;44: 1343–4.
52.
ChiesaCPaneroARossiNStegagnoMDe GiustiMOsbornJFReliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis1998;26: 664–72.
53.
MonneretGLabauneJMIsaacCBienvenuFPutetGBienvenuJ.Increased serum procalcitonin levels are not specific to sepsis in neonates. Clin Infect Dis1998;27: 1559–60.
54.
LapillonneABassonEMonneretGBienvenueJSalleBL. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet1998;35J: 1211–2.
55.
Martin-DenavitTMonneretGLabauneJMIsaacCBienvenuFPutetGUsefulness of procalcitonin in neonates at risk for infection. Clin Chem1999;45: 440.
56.
AssumaMSignoreFPacificoLRossiNOsbornJFChiesaC.Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: A longitudinal study. Clin Chem2000;46: 1583–7.
57.
GendrelDRaymondJAssicotMMoulinFIniguezJ-LLebonPMeasurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis1997;24: 1240–2.
58.
EberhardOKLangefeldIKuseERBrunkhorstFMKliemVSchlittHJProcalcitonin in the early phase after renal transplantation - will it add to diagnostic accuracy?Clin Transplant1998;12: 206–11.
59.
StaehlerCHammerCMeiserBReichartB.Procalcitonin: A new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation. Transplant Proc1997;29: 584–5.
60.
HammerSMeisnerFDirschedlPHöbelGFraunbergerPMeiserBProcalcitonin: A new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation. Transplant Immunol1998;6: 235–41.
61.
KunzDProssWKönigWLippertHMangerT.Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation. Transplant Proc1998;30: 2398–9.
62.
Al-NawasBShahPM. Procalcitonin, a new diagnostic and prognostic marker for severe infections. Clin Microbiol Infect1998;4: 237–41.
